Chromatin is pivotal for regulation of the DNA damage process insofar as it influences access to DNA and serves as a DNA repair docking site. Recent works identify histone chaperones as key regulators of damaged chromatin's transcriptional activity. However, understanding how chaperones are modulated during DNA damage response is still challenging. This study reveals that the histone chaperone SET/TAF-Iβinteracts with cytochrome c following DNA damage. Specifically, cytochrome c is shown to be translocated into cell nuclei upon induction of DNA damage with camptothecin, but not upon stimulation of the death receptor or stress-induced pathways. Cytochrome c was found to competitively hinder binding of SET/TAF-Iβ to core histones, thereby locking its histone binding domains and inhibiting its nucleosome assembly activity. In addition, we have used Nuclear Magnetic Resonance spectroscopy, calorimetry, mutagenesis and molecular docking to provide an insight into the structural features of the formation of the complexbetween cytochrome c and SET/TAF-Iβ. Overall, these findings establish a framework for understanding the molecular basis of cytochrome c-mediated blocking of SET/TAF-Iβ, which subsequentlymay facilitate the development of new drugs to silence the oncogenic effect of its histone chaperone activity.
Introduction
The oncoprotein SET/template-activating factor (TAF)-Iβ (SET/TAF-Iβ) -also known as inhibitor-2 of protein phosphatase-2A (I 2 PP2A) and inhibitor of histone acetyltransferase (INHAT) -belongs to the nucleosome assembly protein (NAP) family of histone chaperones. SET/TAF-Iβ participates in numerous of cellular processes, including cell cycle control (1), apoptosis (2) , transcription regulation (3) and chromatin remodelling (4) . Many recent studies highlight the chromatin-related properties of SET/TAF-Iβ. As a histone chaperone, SET/TAF-Iβ associates to core histones to shield their positive charge, preventing improper contact with DNA and facilitating the correct deposition of free histones onto DNA for nucleosome formation (5) .
Recent work points to the crucial role of chromatin dynamics in DNA damage response (6) (7) (8) . In fact, histone chaperones have emerged as key players in the transient disorganization of chromatin required in the DNA repair process. Thus, the histone chaperones aprataxin-PNK-like factor (APLF) (6) , antisilencing function 1 (Asf1) (9) , chromatin assembly factor 1 (CAF-1) (10), death domain-associated protein 6 (DAXX) (11) , facilitating chromatin transcription (FACT) (12) , histone regulator A (HIRA) (13) , nucleolin (14) , p400 (15) , nucleosome assembly protein 1-like 1 (NAP1L1) and 1-like 4 (NAP1L4) (7) are recruited to damaged chromatin, thereby promoting histone dynamics in response to DNA damage. Recently, SET/TAF-1β was found to modulate the DNA damage response by regulating chromatin compaction (16) .
Recently, we have identified SET/TAF-Iβ as a target protein for cytochrome c (Cc) following the release of the latter from mitochondria in human cells treated with apoptotic agents (17, 18) . While it has been shown that the hemeprotein Cc serves as an electron carrier between complexes III and IV in the mitochondrial respiratory chain, its role in nuclei has yet to be convincingly elucidated. It has been proposed, however, that Cc accumulation in the nucleus under apoptotic stimuli relates to nuclear pyknosis, DNA fragmentation (19) and chromatin remodelling (20) . Here, we show that the SET/TAF-Iβ oncoprotein interacts with Cc in the cell nucleus in response to treatment of the cell with camptothecin (CPT), a well-known inducer of DNA damage and apoptosis, but not to treatment with other apoptosis-inducing chemical agents. We also demonstrate that Cc impairs the histone chaperone activity of SET/TAF-Iβ through competitive binding, thereby preventing the formation of core histone-SET/TAF-Iβ complexes. cation of Cc-GFP from mitochondria to the cytoplasm and the nucleus. The nuclear localization of Cc-GFP has been confirmed by colocalization with the Hoechst staining ( Fig. 1A: right) . In addition, subcellular fractionation of Heltog cells treated with 20 μM CPT showed Cc accumulation in the cell nucleus after 4 h (Fig. 1B) . In fact, Cc appeared in the nucleus after 1 h treatment, as previously observed in HeLa cells treated with either UV irradiation or CPT (20) . Co-detection in the nuclear cell fraction with nuclear-specific poly (ADP-ribose) polymerase (PARP) confirmed the Cc translocation into the nucleus (Fig.  1B ).
Results

Cc interacts with SET/TAF-
To further demonstrate the relationship between endogenous SET/TAF-Iβ and Cc in response to DNA damage, in cell interaction between them was examined using immunoprecipitation (IP). An antibody against Cc was used to extract associated proteins in nuclear lysates of Heltog cells treated with 20 μM CPT for 4 h. As shown in Fig. 1C , SET/TAF-Iβ co-immunoprecipitated with Cc after CPT treatment (lane 5), while untreated cells (control) did not show any band corresponding to SET/TAF-Iβ (lane 2). To confirm the IP specificity, nuclear lysates from untreated and CPT-treated cells were probed with the SET/TAF-Iβ antibody (Fig. 1C: lanes 1 and 4, respectively) , while the negative controls (Fig. 1C: lanes 3 and 6) did not show any band when mouse immunoglobulin G was used. Cc IP was confirmed by immunoblotting the same membrane with the anti-Cc antibody (Fig. 1C) .
To examine whether the observed Cc:SET/TAF-Iβ interaction is restricted to cells experiencing DNA damage, the effect of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and staurosporine (STP) -two well-known apoptosisinducing agents for which DNA damage is not an initiating event -was studied. TRAIL is a member of the TNF superfamily either by the extrinsic pathway or by the BH3 interacting-domain death agonist (Bid)-mediated mitochondrial pathway (21) . STP is a broad-spectrum protein kinase inhibitor that promotes intracellular stress-induced apoptosis (22) . Apoptosis induction with TRAIL or STP may result in DNA damage in later stages of treatment. Therefore, cell cultures were first tested to determine whether they exhibited DNA damage following TRAIL-or STPinduced apoptosis. To this end, Heltog cell lysates were treated with 100 ng/ml TRAIL or 1 μM STP for 1, 2, 4 and 8 h and immunoblotted against Ser139-phosphorylated histone H2AX (γ-H2AX). γ-H2AX is an extremely sensitive marker of DNA damage as it accumulates rapidly in response to double-strand breaks (DSBs). As shown, the DNA-damage-dependent accumulation of γ-H2AX occurs after 4 h or 8 h of treatment with TRAIL and STP, respectively (Fig. 1D ). By contrast, CPT promotes histone H2AX phosphorylation after 1 h. Since no significant DNA damage was observed following exposure to TRAIL for 2   137  138  139  140  141  142  143  144  145  146  147  148  149  150  151  152  153  154  155  156  157  158  159  160  161  162  163  164  165  166  167  168  169  170  171  172  173  174  175  176  177  178  179  180  181  182  183  184  185  186  187  188  189  190  191  192  193  194  195  196  197  198  199  200  201  202  203  204   2 www.pnas.org ------Footline Author   205  206  207  208  209  210  211  212  213  214  215  216  217  218  219  220  221  222  223  224  225  226  227  228  229  230  231  232  233  234  235  236  237  238  239  240  241  242  243  244  245  246  247  248  249  250  251  252  253  254  255  256  257  258  259  260  261  262  263  264  265  266  267  268  269  270  271  272 Submission PDF h or STP for 4 h, these exposure times were selected to further explore Cc localization. Consequently, following the exposure of Heltog cell cultures to 100 ng/ml TRAIL for 2 h or 1 μM STP for 4 h, subcellular fractionation was applied, indicating Cc as having been translocated from mitochondria to cytosol, but not to the nucleus (Fig. 1E ). This corresponds to findings in previous studies of Cc release from mitochondria in response to TRAIL and STP (23, 24) . Nevertheless, our study shows Cc as having been unable to reach the cell nucleus following treatments with TRAIL or STP (Fig. 1E ). This contrasts with the presence of Cc in the nucleus observed in response to CPT-induced DNA damage ( Fig. 1A and B) . Altogether, these results indicate that a specific DNA-damage stimulus (CPT) triggers nuclear translocation of Cc, thereby permitting binding to its nuclear target SET/TAF-Iβ.
Cc binds to SET-TAF-Iβ and blocks histone binding
In order to explore the biological significance of the Cc:SET/TAF-Iβ interaction in the cell nucleus in response to a DNA-damage stimulus, we tested the ability of Cc to prevent histone binding to SET/TAF-Iβ. Hence, an electrophoretic mobility shift assay (EMSA) was performed to detect complex formation between SET/TAF-Iβ and calf thymus histones and to further study the effect of the addition of Cc. The mobility of the histone mixture, as well as Cc and SET/TAF-Iβ, are shown in Fig. 2A (lanes 1 to 3) . Due to their opposite charges, Cc and SET/TAF-Iβ migrated in reverse directions. The lower mobility of SET/TAF-Iβ following histone addition ( Fig. 2A: lane 4) indicates the formation of chaperone-histone complexes. The addition of Cc at increasing concentrations to the SET/TAF-Iβ and histone mixture ( Fig. 2A: lanes 5 to 14) , made the chaperone mobility match that observed for the Cc:SET/TAF-Iβ complex (lane 15) , revealing that Cc competes with histones for the SET/TAF-Iβ binding site.
To confirm the EMSA results, Nuclear Magnetic Resonance (NMR) measurements of reduced Cc were recorded in the presence of SET/TAF-Iβ and Xenopus laevis core histones H2B, H3 and H4. The use of isolated core histones allowed for a comparison of their respective binding affinities for the chaperone in competition with Cc. However, binding to core histone H2A could not be tested, as the recombinant expression of H2A was not possible. Specifically, the Met80-εCH 3 NMR signal of the methionine axial ligand of Cc (Met80) was monitored. As shown, this signal broadens beyond the detection limit upon the addition of SET/TAF-Iβ (Fig. 2B ). This is due to the long diffusional correlation time of Cc bound to SET/TAF-Iβ, which results in a fast signal relaxation. As expected for a binding competition, titration of the Cc:SET/TAF-Iβ solution with increasing concentrations of H2B, H3 or H4 core histones led to dissociation of Cc from SET/TAF-Iβ and the recovery of the Met80-εCH 3 signal. Circular dichroism (CD) spectra of SET/TAF-Iβ and core histones H2B, H3 and H4 corroborated the proper secondary structure organization of the proteins (Fig. S1) .
To compare the binding thermodynamics of the complexes formed by SET/TAF-Iβ with Cc and core histones, Isothermal Titration Calorimetry (ITC) experiments were performed. Measurements revealed the interaction between Cc and SET/TAF-Iβ being slightly exothermic and entropically driven (binding enthalpy, △H, -0.9 kcal mol -1 ) with a dissociation constant (K D ) of 3.1 μM and a Cc:SET/TAF-Iβ stoichiometry of 2:1 at 25 ºC (Table  1) . Notably, the binding of Cc to SET/TAF-Iβ exhibited weak positive cooperativity (Fig. S2) , yielding a cooperativity constant (k) of 3.8 and leading to a smaller K D value and a very positive enthalpy of interaction for the second site (Table 1) . In other words, the binding of the first Cc molecule increases 3.8 times the affinity for the binding of a second Cc molecule to SET/TAF-Iβ. Cooperativity can be ascribed to direct ligand-ligand interactions or to protein conformational changes. Therefore, it might be plausible that, following the binding of the first Cc molecule, SET/TAF-Iβ undergoes a conformational change that facilitates the interaction with the second Cc molecule.
As before, ITC experiments were used to quantitatively assess the binding of SET/TAF-Iβ to the core histones H2B, H3 and H4 from Xenopus laevis. As shown, (Fig. S3, Table 1 ) H3 binds SET/TAF-Iβ with a lower affinity (K D = 25 μM) than H2B (K D = 2 μM) or H4 (K D = 6 μM). These values agree with those previously reported for the interaction of SET/TAF-Iβ with H2B (K D = 2.87 μM), but differ slightly for H3 (K D = 0.15 μM) (25) . In all cases, the stoichiometry of histone:SET/TAF-Iβ interactions was 2:1 ( Table 1) .
The SET/TAF-Iβ histone binding domain is engaged during binding to Cc
Considering that Cc binds to SET/TAF-Iβ and affects its interaction with core histones, we aimed at determining whether Cc recognizes the SET/TAF-Iβ histone-binding domain. SET/TAF-Iβ forms a headphone-shaped homodimer, each monomer consisting of an N-terminus, a backbone helix, an "earmuff" domain and an acidic disordered stretch (5) (Fig. S4) . The region of SET/TAF-Iβ responsible for histone binding and chaperone activity comprises the lower area of the so-called "earmuff" domain (5). In order to examine the SET/TAF-Iβ region involved in binding to Cc, two different SET/TAF-Iβ deletion mutants were designed. The first included the N-terminus along with the backbone helix (hereafter referred to as SET/TAF-Iβ [amino acids 1 to 80]), whereas the second (hereafter referred to as SET/TAF-Iβ [amino acids 81 to 277]) encoded the "earmuff" domain and the acidic stretch of the C-terminus. Worth particular mention is that CD spectra of both mutants indicated a secondary structure similar to that of the wild-type protein (Fig. S1) . ITC of Cc interactions with SET/TAF-Iβ and SET/TAF-Iβ (81-277) showed the binding reaction in both cases (Fig. S5: upper) . However, weak calorimet-273  274  275  276  277  278  279  280  281  282  283  284  285  286  287  288  289  290  291  292  293  294  295  296  297  298  299  300  301  302  303  304  305  306  307  308  309  310  311  312  313  314  315  316  317  318  319  320  321  322  323  324  325  326  327  328  329  330  331  332  333  334  335  336  337  338  339  340 Submission PDF ric signals in the thermogram of SET/TAF-Iβ throughout the titration with Cc ( Fig. S5 : upper) suggest a weak interaction with an estimated K D of 44 μM (Table 1) . On the contrary, the affinity between Cc and SET/TAF-Iβ (81-277) was higher and yielded a K D of 9.6 μM. The results indicate a binding preference of Cc for the C-terminus of SET/TAF-Iβ and explain the way Cc hampers the chaperone's ability to bind to histones. To further confirm the C-terminus of SET/TAF-Iβ as the region interacting with Cc, two SET/TAF-Iβ mutants were obtained by replacing three adjacent amino acid residues from the "earmuff" domain by alanine residues (Fig. S4) . Mutants S162A/K164A/D165A and T191A/T194A/D195A (Fig. S4 : green and red, respectively) failed to bind to histones and demonstrated significantly reduced histone chaperone activity (35% of wild-type activity) (5) . According to the calorimetric data resulting from the titrations of the two SET/TAF-Iβ triple mutants with Cc ( Fig. S5 : lower panels), the S162A/K164A/D165A mutant shows a higher affinity towards Cc (K D = 6.3 μM) than T191A/T194A/D195A (K D = 22 μM). These findings suggest that threonine residues at positions 191 and 194 and aspartate at 195, located in the lower region of the "earmuff" domain, are involved in the interaction with Cc, as they are in the histone remodelling activity of SET/TAF-Iβ.
SET/TAF-Iβ histone chaperone activity is impaired by Cc As binding to core histones is essential for the histone chaperone activity of SET/TAF-Iβ, the ability (or inability) of Cc to affect such activity was tested using a supercoiling assay (Fig.  S6) . As shown, SET/TAF-Iβ assembled nucleosomes through the introduction of negative supercoils in the DNA plasmid in the presence of Topoisomerase I (Topo I) and core histones (Fig.  2C: lane 3) . Strikingly, the chaperone activity of SET/TAF-Iβ was found to have been impaired following the addition of Cc Submission PDF in increasing concentrations (Fig. 2C: lane 4 to 6) . Controls corresponding to the supercoiling assay in the presence of isolated SET/TAF-Iβ, HeLa core histones, Cc or a combination are also shown (Fig. S7) . Altogether, these findings unequivocally demonstrate that Cc binds to SET/TAF-Iβ and strongly hinders its ability to function as a histone chaperone.
The Cc heme crevice faces SET/TAF-Iβ upon binding To dig into the structural features of the interaction between Cc and SET/TAF-Iβ, the Cc:SET/TAF-Iβ interaction was monitored by recording [ 1 H, 15 N] Heteronuclear Single-Quantum Correlation (HSQC) spectra of fully reduced 15 N-labelled Cc, which was either free or bound to unlabeled SET/TAF-Iβ. Titration of SET/TAF-Iβ onto 15 N Cc resulted in a significant broadening of the Cc resonances, thereby suggesting the formation of the Cc:SET/TAF-Iβ complex (Fig. 3A) . Additionally, specific resonances from residues at the complex interface may show enhanced broadening. Consequently, the line-widths (△△ν 1/2Binding ) of 15 N-labelled Cc resonances were analyzed in a pure Cc sample and a 1:0.25 Cc:SET/TAF-Iβ mixture . Signals showing this effect corresponded to Thr19, Lys39, Gly41, Gln42, Tyr48, Lys79, Ile81, Ala92 and Leu94 in the 15 N dimension (Fig. S8) . Hence, these residues can be expected to be at or near the region of Cc interacting with SET/TAF-Iβ.
In addition to specific line broadening, several amide resonances in the [ 1 H, 15 N] HSQC spectra of Cc exhibit chemicalshift perturbations (CSPs) in the presence of SET/TAF-Iβ (Fig.  3A) . For instance, the details of the superimposed spectra (Fig.  S9A) shows that Ala50 and Glu89 resonances shift gradually at increasing Cc:SET/TAF-Iβ ratios (1:0.06, 1:0.12 and 1:0.25). These CSPs indicates that these residues experienced a change in their chemical environment in the presence of SET/TAF-Iβ. Then, they may belong to the complex interface.
In order to identify the residues involved in the complex interface, an average CSP analysis (△δ Avg ) of the Cc amide signals was obtained. As shown, 15 N Cc resonances from Gln16, Gly77, Val83, Lys88, Glu89 and Asp93 experience significant chemical shifts (△δ Avg ≥ 0.075) following binding to SET/TAF-Iβ (Fig.  S9B) . Strikingly, residues of 15 N Cc demonstrating CSPs are located on the N-and C-terminus regions on the side of the exposed heme periphery (Fig. 3B) .
Notably, a similar surface patch of Cc is involved in the interactions with cytochrome c oxidase (26) and cytochrome bc 1 (27) in the mitochondrial respiratory chain. Interestingly, the interaction between Cc and the SET/TAF-Iβ chaperone implicated ten lysine residues -namely 5, 7, 8, 22, 25, 53, 72, 73, 86 and 88 (Fig. 3B) thereby evidencing the key role of electrostatic forces in the formation of Cc:SET/TAF-Iβ complexes. Similarly, lysine residues are also involved in the interaction with cytochrome bc 1 (27, 28) . Given the well-known "lysine masking activity" of SET/TAF-Iβ that prevents the acetylation of histone lysines inside the INHAT complex (3), it is plausible that SET/TAF-Iβ also recognizes the lysine residues from Cc.
Intriguingly, the Cc residues thought to play an important role in the interaction between the hemeprotein and apoptosis protease-activating factor-1 (Apaf-1) -namely, Lys7, Lys25, Lys39 and Lys72 (29) -perfectly match those identified in this study as interacting with SET/TAF-Iβ. Furthermore, whereas studies of the complex formed between Cc and pro-survival protein Bcl-x L identified both His26 and Gly41 as the most important Cc residues affected upon binding (30) , the present study shows a change only in Gly41 following the addition of SET/TAF-Iβ to the Cc sample.
A structural look into the Cc:SET/TAF-Iβ complex and NMRbased molecular docking models
With the aim of defining Cc:SET/TAF-Iβ complex interface regions, NMR restraint-driven docking was performed. CSPs obtained from NMR analysis of the Cc:SET/TAF-Iβ complex at a 1:0.25 ratio were used as input data. From the 500 solutions obtained from the NMR-based docking for Cc:SET/TAF-Iβ (Fig.  S10A) , Cc geometric centres are represented around Robertson (ribbon) diagrams of SET/TAF-Iβ. In agreement with the two binding sites observed by ITC titrations, the models predicted by the NMR restraint-driven docking yielded two differentiated clusters. One of these clusters included the vast majority of highest scoring models (Fig. S10A: cluster 1) , whereas the second cluster encompassed less than 50 solutions (Fig. S10A: cluster  2) . Interestingly, nearly all the probe solutions are located in the same region of SET/TAF-Iβ -namely, between its "earmuff" domains. This finding supports the data reported in earlier sections of this study suggesting a Cc binding preference for the SET/TAF-Iβ histone-binding domain. Indeed, the highest scoring solution from the first cluster revealed how Cc leans its heme group to approach the lower region of a SET/TAF-Iβ "earmuff" domain (Fig. S10B) . The surface representation of both proteins shows them to be in close contact. A secondary set of Cc structures with higher energies (cluster 2) was found near the backbone helices (Fig. S10C) .
Discussion
Inefficient repair of DNA lesions results in genome instability, which can, in turn, lead to premature aging and cancer (31) . Chromatin dynamics regulate transcriptional activity in response to DNA damage by promoting accessibility to DNA and serving as a docking site for repair and signalling proteins, thereby increasing repair efficiency (8, 32) . Recent works reveal how histone chaperones temporarily evict histones from a damaged site in order to facilitate access of repair factors to DNA lesions (9) . However, once a DNA break is repaired, histone chaperones return histone proteins to the repaired site (33) and promote the recovery of transcriptional activity (7, 13) .
The data presented in this study shows the histone chaperone and oncoprotein SET/TAF-Iβ to specifically interact with Cc in cell nuclei in response to CPT-induced DNA damage. While translocation of Cc to the nucleus had previously been observed (19, 20) , the specific role of Cc in the nucleus has yet to be fully elucidated. However, this work shows Cc translocates into the cell nucleus in response to CPT-induced DNA damage, but not following the TRAIL-activated extrinsic pathway or STPtriggered stress-induced apoptosis. The present study demonstrates that nuclear translocation of Cc occurs early in the DNA damage response -just one hour after CPT treatment. The finding suggests that Cc might be imported into the nucleus by diffusion through the nuclear pore complex, although the precise molecular mechanism is as yet unknown. As neither TRAIL nor STP trigger Cc entry into the cell nucleus, the interaction between Cc and SET/TAF-Iβ seems to be specifically linked to CPTinduced DNA damage.
CPT selectively targets the essential mammalian enzyme Topo I in nuclei (34) . CPT binds covalently to Topo I and supercoiled DNA, thereby forming a ternary complex that inhibits DNA religation and generates a greater number of DSBs (35) . Recently, it has been proposed that histone chaperones play a central role as histone carriers in chromatin disassembly connected with DNA repair and transcription recovery following DNA damage (7, 9, 13, 33) . Thus, histone chaperones such as HIRA (13) , FACT (12) , nucleolin (14) , APLF (6) Asf1 (9), CAF-1 (10), DAXX (11), p400 (15), NAP1L1 and NAP1L4 (7) actively promote transient chromatin disorganization and histone reshaping in response to DNA damage (8) . Since SET/TAF-Iβ belongs to the NAP1 family, it is tempting to hypothesize a role -similar to that described for the above mentioned histone chaperones -for SET/TAF-Iβ in chromatin reshaping in response to DNA 545  546  547  548  549  550  551  552  553  554  555  556  557  558  559  560  561  562  563  564  565  566  567  568  569  570  571  572  573  574  575  576  577  578  579  580  581  582  583  584  585  586  587  588  589  590  591  592  593  594 Submission PDF lesions. Such a role would also explain the Cc-mediated inhibition observed here.
The results of ITC and NMR titrations performed in the present study reveal the oncoprotein SET/TAF-Iβ as binding specifically to Cc. Interestingly, Cc uses the surface residues surrounding its heme group to interact with the histone chaperone, as it does with its respiratory partners cytochrome c oxidase (26) and cytochrome bc 1 (27) , and its apoptotic partner Apaf-1 (29) .
Mutagenesis and NMR-based docking analysis carried out here demonstrated that Cc docks between the two histone binding domains of SET/TAF-Iβ, thereby preventing the binding of the latter to core histones. Therefore, and as inferred from nucleosome assembly activity assays, it may be concluded that Cc not only binds to SET/TAF-Iβ, but also hampers the latter's histone chaperone activity. It may therefore be proposed that, following DNA damage induced by CPT, the translocation of Cc into the cell nucleus and resulting core histone displacement may hinder SET/TAF-Iβ nucleosome assembly activity (Fig. 4) . Thus, the specific inhibition of SET/TAF-Iβ by Cc could contribute not only to the suppression of the former's normal chaperone activity when apoptosis is inevitable and such activity is no longer necessary, but also to obstruct nucleosome remodelling that follows DNA damage repair.
Our finding that Cc interacts with the oncoprotein SET/TAF-Iβ upon its release from mitochondria suggests that the role of Cc in the execution of apoptosis is wider than previously held, insofar as it goes beyond caspase cascade activation, by also inhibiting pro-survival Cc partners. To our knowledge, the SET/TAF-Iβ oncoprotein is indeed the first Cc target in the nucleus to be identified either in homeostasis or during apoptosis. The results presented not only reveal the molecular basis for the blocking of SET/TAF-Iβ activity by Cc, but also suggest that the inhibition of this oncoprotein could be a promising objective in the development of anti-cancer drugs. More specifically, an understanding of the molecular interfaces in the complex formed by SET/TAF-Iβ □and its inhibitor, Cc, could facilitate the development of new drugs aimed at silencing the oncogenic effect of SET/TAF-Iβ histone chaperone activity.
Material and Methods
Expression and purification protocols of Cc, wild-type SET/TAF-Iβ, SET/TAF-Iβ , SET/TAF-Iβ (81-277), mutants S162A/K164A/D165A and T191A/T194A/D195A, and Xenopus laevis core histones H2B, H3 and H4 are described in SI Materials and Methods. Experimental details of apoptosis induction, subcellular fractionation, Western blot analysis, IP, ITC, EMSA, CD, NMR, nucleosome assembly assays and molecular docking calculations are likewise described in SI Materials and Methods.
